Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /6677

Anxo Pharmaceutical Co., Ltd.

6677

• TPEX: 6677 • Delayed

19.75TWD -2.2%

0.6278 USD

As of 5 June 2026, Anxo Pharmaceutical Co., Ltd. has a market cap of $35.88M USD, ranking #32984 globally and #2016 in Taiwan. It ranks #2977 in the Healthcare sector, and #174 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

32984

Country Rank

2016

Sector Rank

2977

Industry Rank

174

Key Stats

Market Cap

$35.88MUSD

1.13B TWD

Enterprise Value

$52.43MUSD

1.65B TWD

Revenue (TTM)

$28.08MUSD

883.22M TWD

EBITDA (TTM)

$395.65KUSD

12.45M TWD

Net Income (TTM)

-$1.35MUSD

-42.34M TWD

EBITDA Margin

1.4%

Profit Margin

-4.8%

PS Ratio

1.3

PB Ratio

1.0

EV/EBITDA

60.8

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Linquan Yan open_in_new

Founded

2003

Website

anxo.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.2%	0.5%	3.1%	3.6%	-20%	6.7%	11%	-60%	-28%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6677 瑩碩生技醫藥股份有限公司 Ordinary Shares ISIN: TW0006677008 Shares Out.: Shares Outstanding: 56.039M¹ TV: TradingView: TPEX: 6677 SA: Stock Analysis: TPEX: 6677 YF: Yahoo Finance: 6677.TWO GF: Google Finance: TPEX: 6677 BA: Barron's: 6677 MS: Morningstar: ROCO: 6677	19.75 TWD	TV: TradingView: TPEX: 6677 SA: Stock Analysis: TPEX: 6677 YF: Yahoo Finance: 6677.TWO GF: Google Finance: TPEX: 6677 BA: Barron's: 6677 MS: Morningstar: ROCO: 6677

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Anxo Pharmaceutical Co., Ltd.

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroenterology, anti-infectives/anti-viruses, hemodialysis/urinary system, respiratory system/antihistamine, analgesics, and others; and injections. The company was founded in 2003 and is headquartered in Taipei, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Bora Pharmaceuticals Co., Ltd. TWSE: 6472	$1.68B 52.95B TWD 5K%	17.9	Taiwan
Grape King Bio Ltd. TWSE: 1707	$536.85M 16.89B TWD 1K%	14.0	Taiwan
Daiken Biomedical Co., Ltd. TWSE: 7780	$476.38M 14.99B TWD 1K%	36.5	Taiwan
TCI Co., Ltd. TPEX: 8436	$415.07M 13.06B TWD 1K%	13.7	Taiwan
Microbio Co., Ltd. TPEX: 4128	$291.68M 9.18B TWD 713%	-	Taiwan
Intelligene Inc. TPEX: 7832	$244.3M 7.69B TWD 581%	-	Taiwan

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.93B 108.92B ILS 106K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 82K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 44K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 31K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 31K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 25K%	80.6	China

chevron_leftBack